Searchable abstracts of presentations at key conferences in endocrinology

ea0050p336 | Obesity and Metabolism | SFEBES2017

Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy

Dimitriadis Georgios K , Randeva Harpal S , Grammatopoulos Dimitris K , Barber Thomas M

Aim: To explore the metabolic phenotype of Male Obesity-associated Secondary Hypogonadism (MOSH) and following treatment with long-acting intramuscular (IM) testosterone undecanoate.Methods: A prospective observational pilot study on metabolic effects of IM testosterone undecanoate in MOSH (Hypogonadal [HG] group, n=13), including baseline comparisons with controls (Eugonadal [EG] group, n=15). Half the subj...

ea0050p336 | Obesity and Metabolism | SFEBES2017

Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy

Dimitriadis Georgios K , Randeva Harpal S , Grammatopoulos Dimitris K , Barber Thomas M

Aim: To explore the metabolic phenotype of Male Obesity-associated Secondary Hypogonadism (MOSH) and following treatment with long-acting intramuscular (IM) testosterone undecanoate.Methods: A prospective observational pilot study on metabolic effects of IM testosterone undecanoate in MOSH (Hypogonadal [HG] group, n=13), including baseline comparisons with controls (Eugonadal [EG] group, n=15). Half the subj...

ea0016oc3.3 | Diabetes and obesity | ECE2008

Regulation of lipolysis by corticotropin releasing hormone in brown adipocytes

Markovic Danijela , Digby Janet E , Lehnert Hendrik , Pessin Jeffery , Grammatopoulos Dimitris K

Corticotropin releasing hormone (CRH) and its related peptides, urocortins (UCN), are now emerging as critical regulators of energy balance and homeostasis. These peptides exert their effects through activation of two types of CRH receptors (CRH-R1 and CRH-R2). The role of these peptides as regulators of mammalian thermogenesis and their effects on brown adipose tissue (BAT) have been primarily attributed to modulation of brain centres controlling sympathetic outflow. However,...

ea0050p224 | Diabetes and Cardiovascular | SFEBES2017

UHCW audit on SGLT2 inhibitor (SGLT2-i) use

Mytilinaiou Maria , Dimitriadis Georgios K , Davasgaium Allan , Sambrook Diane , Hewins Claire , Nalawade Nilisha , Grammatopoulos Dimitris K , Randeva Harpal S

Aim: After almost 2 centuries, SGLT2-i have made their comeback in human pharmacology through successful re-introduction in diabetes type 2 (T2D). Via restriction of renal glucose reabsorption, SGLT2-i have shown promising results. The aim of this audit was to ensure that current practice at UHCW NHS Trust is in line with the agreed national standards, whilst collecting clinical data from the use of SGLT2-i.Methods: This...

ea0050p224 | Diabetes and Cardiovascular | SFEBES2017

UHCW audit on SGLT2 inhibitor (SGLT2-i) use

Mytilinaiou Maria , Dimitriadis Georgios K , Davasgaium Allan , Sambrook Diane , Hewins Claire , Nalawade Nilisha , Grammatopoulos Dimitris K , Randeva Harpal S

Aim: After almost 2 centuries, SGLT2-i have made their comeback in human pharmacology through successful re-introduction in diabetes type 2 (T2D). Via restriction of renal glucose reabsorption, SGLT2-i have shown promising results. The aim of this audit was to ensure that current practice at UHCW NHS Trust is in line with the agreed national standards, whilst collecting clinical data from the use of SGLT2-i.Methods: This...